Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 3051-3057

  Szalowska, Ewa ^a   Elferink, Marieke G L ^a   Hoek, Annemiek ^b   Groothuis, Geny M M ^a   Vonk, Roel J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENERGY METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER; OMENTUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE CULTURE; UPREGULATION;

EID: 68549090621     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-2787     Document Type: Article

References (40)

1. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA 2001 The hormone resistin links obesity to diabetes. Nature 409:307-312
2. Pang SS, Le YY 2006 Role of resistin in inflammation and inflammation-related diseases. Cell Mol Immunol 3:29-34
3. Muse ED, Lam TK, Scherer PE, Rossetti L 2007 Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117:1670-1678
4. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, O'Rahilly S 2001 Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-action in humans. Diabetes 50:2199-2202
5. Nagaev I, Smith U 2001 Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561-564
6. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA 2003 Resistin is expressed in human macrophages and directly regulated by PPAR γ activators. Biochem Biophys Res Commun 300:472-476
7. McTernan PG, McTernan CL, Chetty R, Jenner K, Fisher FM, Lauer MN, Crocker J, Barnett AH, Kumar S 2002 Increased resistin gene and protein expression in human abdominal adipose tissue. J Clin Endocrinol Metab 87:2407
8. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S 2002 Resistin, central obesity, and type 2 diabetes. Lancet 359:46-47
9. Virkamäki A, Yki-Järvinen H 1994 Mechanisms of insulin resistance during acute endotoxemia. Endocrinology 134:2072-2078
10. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, Tompkins RG, Martyn JA 2002 Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282:E386-E394
11. Agwunobi AO, Reid C, Maycock P, Little RA, Carlson GL 2000 Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 85:3770-3778
12. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmée E, Cousin B, Sulpice T, Chamontin B, Ferrières J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC, Burcelin R 2007 Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761-1772
13. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, Burcelin R 2008 Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57:1470-1481
14. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR 2003 Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309:286-290
15. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL 2002 Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 530:158-162
16. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA 2004 An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med 1:e45
17. Rajala MW, Lin Y, Ranalletta M, Yang XM, Qian H, Gingerich R, Barzilai N, Scherer PE 2002 Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue. Mol Endocrinol 16:1920-1930
18. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R 2001 Tumor necrosis factor α is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem Biophys Res Commun 288:1027-1031
19. Bertolani C, Sancho-Bru P, Failli P, Bataller R, Aleffi S, DeFranco R, Mazzinghi B, Romagnani P, Milani S, Ginés P, Colmenero J, Parola M, Gelmini S, Tarquini R, Laffi G, Pinzani M, Marra F 2006 Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am J Pathol 169:2042-2053
20. Pagano C, Soardo G, Pilon C, Milocco C, Basan L, Milan G, Donnini D, Faggian D, Mussap M, Plebani M, Avellini C, Federspil G, Sechi LA, Vettor R 2006 Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab 91:1081-1086
21. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ 2005 Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111:932-939
22. Sheng CH, Di J, Jin Y, Zhang YC, Wu M, Sun Y, Zhang GZ 2008 Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 33:135-143
23. Brouwers MA, Peeters PM, de Jong KP, Haagsma EB, Klompmaker IJ, Bijleveld CM, Zwaveling JH, Slooff MJ 1997 Surgical treatment of giant haemangioma of the liver. Br J Surg 84:314-316
24. Elferink MG, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJ, Meijer DK, Groothuis GM 2004 LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol Gastrointest Liver Physiol 287:G1008-G1016
25. Olinga P, Merema M, Hof IH, de Jong KP, Slooff MJ, Meijer DK, Groothuis GM 1998 Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab Dispos 26:5-11
26. Alvarez-Llamas G, Szalowska E, de Vries MP, Weening D, Landman K, Hoek A, Wolffenbuttel BH, Roelofsen H, Vonk RJ 2007 Characterization of the human visceral adipose tissue secretome. Mol Cell Proteomics 6:589-600
27. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
28. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408
29. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
30. de Jonge HJ, Fehrmann RS, de Bont ES, Hofstra RM, Gerbens F, Kamps WA, de Vries EG, van der Zee AG, te Meerman GJ, ter Elst A 2007 Evidence based selection of housekeeping genes. PLoS ONE 2:e898
31. Curat CA, Wegner V, Sengenès C, Miranville A, Tonus C, Busse R, Bouloumié A 2006 Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 49:744-747
32. Mu H, Ohashi R, Yan S, Chai H, Yang H, Lin P, Yao Q, Chen C 2006 Adipokine resistin promotes in vitro angiogenesis of human endothelial cells. Cardiovasc Res 70:146-157
33. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH 2000 Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28:458-461
34. Elferink MG, Olinga P, Draaisma AL, Merema MT, Bauerschmidt S, Polman J, Schoonen WG, Groothuis GM 2008 Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity. Toxicol Appl Pharmacol 229:300-309
35. Casas JP, Shah T, Hingorani AD, Danesh J, Pepys MB 2008 C-reactive protein and coronary heart disease: a critical review. J Intern Med 264:295-314
36. Pepys MB, Hirschfield GM, Tennent GA, Gallimore JR, Kahan MC, Bellotti V, Hawkins PN, Myers RM, Smith MD, Polara A, Cobb AJ, Ley SV, Aquilina JA, Robinson CV, Sharif I, Gray GA, Sabin CA, Jenvey MC, Kolstoe SE, Thompson D, Wood SP 2006 Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440:1217-1221
37. Haider DG, Leuchten N, Schaller G, Gouya G, Kolodjaschna J, Schmetterer L, Kapiotis S, Wolzt M 2006 C-reactive protein is expressed and secreted by peripheral blood mononuclear cells. Clin Exp Immunol 146:533-539
38. Wajchenberg BL 2000 Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21:697-738
39. Wajchenberg BL, Giannella-Neto D, da Silva ME, Santos RF 2002 Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome. Horm Metab Res 34:616-621
40. Poulain-Godefroy O, Lecoeur C, Pattou F, Frühbeck G, Froguel P 2008 Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol Regul Integr Comp Physiol 295:R1-R7